Latest Commercialisation News

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.

Wide Open Agriculture reports a remarkable 243% jump in cash receipts driven by soaring lupin protein sales and secures a strategic foothold in China through an exclusive distribution deal.

Botanix Pharmaceuticals reports a strong commercial ramp-up for Sofdra™, with net revenue jumping from $0.7 million to $4.3 million in one quarter, supported by a $40 million capital raise and a $30 million debt facility.

Nimy Resources reports impressive high-grade gallium assays from its Block 3 East drilling campaign, advancing towards a maiden JORC-compliant resource at the Mons Project. The company also strengthens its metallurgical research partnerships and secures fresh capital to fuel ongoing exploration.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.

Carnegie Clean Energy has signed a pivotal Memorandum of Understanding with BiMEP to develop a 6MW wave energy array in Spain’s Basque Country, marking a significant step in commercialising its CETO technology.

Sovereign Metals’ latest testwork confirms Kasiya graphite’s premium quality amid sweeping US tariffs on Chinese imports, spotlighting its potential as a strategic non-Chinese supply source for battery manufacturers.

Invictus Energy is preparing to drill the high-impact Musuma-1 exploration well outside its Mukuyu discovery area, while securing National Project Status for its Cabora Bassa Project in Zimbabwe.

BlinkLab is advancing its FDA 510(k) clinical trials for autism and ADHD diagnostics, completing its U.S. autism pilot phase and expanding European ADHD recruitment. A recent $7.66 million capital raise supports these efforts as the company targets regulatory approvals in 2026.

Echo IQ has secured a strategic collaboration with the Mayo Clinic Platform and raised $17.3 million, advancing its AI-driven cardiology tools towards FDA clearance and US commercial scale.